APC has published two new pages on a4pc.org that spell out our policy recommendations on peptides and on desiccated thyroid extract (DTE). Together, they give members a clear statement of where APC stands on two closely watched issues in compounding. Here’s what you’ll find on each page.
Peptides. Our issue brief, our recommendation letter to the Pharmacy Compounding Advisory Committee, and our memo to FDA on enforcement authority. The page also collects recent media coverage of the issue and a message from our CEO.
DTE. Our issue brief, our letters to FDA, and our citizen petition, along with a timeline of our updates since FDA's August 2025 notice. There's also a section on how to help your DTE patients be heard, including a link where they can share their stories with FDA.
Find the pages at a4pc.org/peptides and a4pc.org/dte or under the Advocacy section on a4pc.org.